Cancer

$25 million in philanthropy makes 2006 a banner year, Cigarroa says

December 12, 2006

It was a transformative year for The University of Texas Health Science Center at San Antonio, highlighted by $25 million in private philanthropy, President Francisco G. Cigarroa, M.D., said Dec. 11 in his annual State of the University Address.


Reflux disease is a warning sign of esophageal cancer

September 19, 2006

Esophageal cancer, which claimed the life of former Gov. Ann Richards on Sept. 13, is a rare but insidious killer that is difficult to detect early, said a San Antonio surgeon who treats the disease.


Finasteride boosts PSA ability to detect prostate cancer

August 22, 2006

The medication finasteride, which after the seven-year Prostate Cancer Prevention Trial (PCPT) was associated with a 24.8 percent reduction of prostate cancer risk among men who took it, has a new feather in its cap – it beefs up the diagnostic power of the prostate-specific antigen (PSA) test.


Cork tree extract puts a cork on prostate cancer growth, study shows

August 8, 2006

An over-the counter herbal supplement derived from the Amur cork tree (Phellodendron amurense) killed a high percentage of cultured prostate cancer cells in studies conducted at The University of Texas Health Science Center at San Antonio.


Health Science Center establishes department of epidemiology and biostatistics

July 25, 2006

Reflecting the importance of measurable analysis in every area of scientific discovery, the Health Science Center has created a department of epidemiology and biostatistics in its School of Medicine, and has appointed Brad H. Pollock, Ph.D., M.P.H., professor and chair.


Director of the San Antonio Cancer Institute appointed

July 25, 2006

William Henrich, M.D., M.A.C.P., dean of the Health Science Center’s School of Medicine and vice president for medical affairs, and Karen Fields, M.D., president and CEO at the Cancer Therapy and Research Center (CTRC), are pleased to announce that the Health Science Center and the CTRC have jointly recruited one of the nation’s outstanding oncologists, Tyler Curiel, M.D., to lead the San Antonio Cancer Institute (SACI).